Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Receives $4.08 Consensus Price Target from Analysts

Shares of Bioceres Crop Solutions Corp. (NASDAQ:BIOX) have been assigned an average recommendation of “Hold” from the five analysts that are presently covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, three have issued a hold rating and one has issued a buy rating on the company. The average 12 month price objective among brokerages that have covered the stock in the last year is $4.0833.

A number of equities analysts have weighed in on the stock. Canaccord Genuity Group decreased their price target on shares of Bioceres Crop Solutions from $2.50 to $2.25 and set a “hold” rating on the stock in a report on Friday, November 14th. Brookline Capital Management lowered Bioceres Crop Solutions from a “strong-buy” rating to a “hold” rating in a research report on Thursday, August 21st. Weiss Ratings reiterated a “sell (d-)” rating on shares of Bioceres Crop Solutions in a report on Monday, November 17th. Oppenheimer lowered Bioceres Crop Solutions from an “outperform” rating to a “market perform” rating in a research note on Wednesday, October 22nd. Finally, Wall Street Zen upgraded Bioceres Crop Solutions from a “sell” rating to a “hold” rating in a report on Saturday.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of BIOX. Fourth Sail Capital LP grew its stake in Bioceres Crop Solutions by 25.1% during the first quarter. Fourth Sail Capital LP now owns 4,627,669 shares of the company’s stock worth $21,125,000 after buying an additional 928,708 shares during the period. Ardsley Advisory Partners LP lifted its holdings in shares of Bioceres Crop Solutions by 4.7% during the 2nd quarter. Ardsley Advisory Partners LP now owns 993,614 shares of the company’s stock valued at $4,441,000 after acquiring an additional 45,000 shares in the last quarter. Long Focus Capital Management LLC boosted its position in Bioceres Crop Solutions by 11.4% during the 1st quarter. Long Focus Capital Management LLC now owns 829,748 shares of the company’s stock worth $3,788,000 after purchasing an additional 85,000 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in Bioceres Crop Solutions by 9.5% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 823,916 shares of the company’s stock valued at $3,761,000 after purchasing an additional 71,581 shares in the last quarter. Finally, Ballast Asset Management LP increased its holdings in Bioceres Crop Solutions by 69.9% in the 3rd quarter. Ballast Asset Management LP now owns 745,030 shares of the company’s stock valued at $1,048,000 after purchasing an additional 306,624 shares in the last quarter. 17.68% of the stock is owned by institutional investors and hedge funds.

Bioceres Crop Solutions Trading Up 4.0%

Shares of BIOX stock opened at $1.55 on Friday. The firm’s 50-day simple moving average is $1.67 and its 200-day simple moving average is $3.11. The company has a debt-to-equity ratio of 0.19, a current ratio of 0.91 and a quick ratio of 0.62. Bioceres Crop Solutions has a 1-year low of $1.20 and a 1-year high of $7.44. The firm has a market cap of $98.01 million, a P/E ratio of -1.85 and a beta of 0.41.

Bioceres Crop Solutions Company Profile

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.